IPO registrations (S-1, F-1) · Registrants
Inhibitor Therapeutics, Inc.
- SEC CIK
- 1042418 · filings on EDGAR ↗
- Name on the registration
- HedgePath Pharmaceuticals, Inc.
- Former names
- HedgePath Pharmaceuticals, Inc. (2013–2019); COMMONWEALTH BIOTECHNOLOGIES INC (1997–2013)
- Registration
- Form S-1, first filed 2008-04-18, last 2016-07-21; 3 initial registrations, 6 amendments
- Outcome
- Declared effective 2008-04-30; withdrawal requested 2016-03-22
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 4830 W. KENNEDY BLVD., SUITE 600, Tampa, FL 33609
- EIN
- 54-1641133
- Ticker
- INTI (OTC)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Inhibitor Therapeutics, Inc. on the corporate pages
Offering terms
- Shares offered
- 20,000,000
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: INHIBITOR THERAPEUTICS, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: COMMONWEALTH BIOTECHNOLOGIES, INC. EXACT (EIN (EXACT))
- Form D issuer: HedgePath Pharmaceuticals, Inc. EXACT (CIK (EXACT))
- SEC filer: COMMONWEALTH BIOTECHNOLOGIES INC EXACT (CIK (EXACT))
- Person page: Daniel O Hayden Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Francis E O'Donnell Jr Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer,TenPercentOwner))
- Person page: W Mark Watson Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 15
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2008-04-18 | S-1/A | S-1/A (amendment) | COMMONWEALTH BIOTECHNOLOGIES INC | 0001193125-08-084602 ↗ |
| 2008-04-30 | S-1/A | S-1/A (amendment) | COMMONWEALTH BIOTECHNOLOGIES INC | 0001193125-08-097309 ↗ |
| 2008-04-30 | EFFECT | EFFECT (declared effective) | COMMONWEALTH BIOTECHNOLOGIES INC | 9999999995-08-001339 ↗ |
| 2014-09-17 | S-1 | S-1 (registration) | HedgePath Pharmaceuticals, Inc. | 0001193125-14-344411 ↗ |
| 2015-07-22 | S-1/A | S-1/A (amendment) | HedgePath Pharmaceuticals, Inc. | 0001193125-15-259834 ↗ |
| 2015-08-10 | EFFECT | EFFECT (declared effective) | HedgePath Pharmaceuticals, Inc. | 9999999995-15-002228 ↗ |
| 2015-12-17 | S-1 | S-1 (registration) | HedgePath Pharmaceuticals, Inc. | 0001193125-15-406306 ↗ |
| 2016-02-23 | S-1/A | S-1/A (amendment) | HedgePath Pharmaceuticals, Inc. | 0001193125-16-472759 ↗ |
| 2016-03-22 | RW | RW (withdrawal request) | HedgePath Pharmaceuticals, Inc. | 0001193125-16-513431 ↗ |
| 2016-06-17 | S-1 | S-1 (registration) | HedgePath Pharmaceuticals, Inc. | 0001193125-16-624692 ↗ |
| 2016-07-18 | S-1/A | S-1/A (amendment) | HedgePath Pharmaceuticals, Inc. | 0001193125-16-650320 ↗ |
| 2016-07-21 | S-1/A | S-1/A (amendment) | HedgePath Pharmaceuticals, Inc. | 0001193125-16-652618 ↗ |
| 2016-07-22 | EFFECT | EFFECT (declared effective) | HedgePath Pharmaceuticals, Inc. | 9999999995-16-005218 ↗ |
| 2017-04-25 | EFFECT | EFFECT (declared effective) | HedgePath Pharmaceuticals, Inc. | 9999999995-17-000932 ↗ |
| 2018-04-17 | EFFECT | EFFECT (declared effective) | HedgePath Pharmaceuticals, Inc. | 9999999995-18-000838 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2016-07-21 | S-1/A | registration statement | $0.10 | 20,000,000 | $2,000,000 | 0 | primary document; price sentence, shares headline, proceeds computed | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| SEARS SAMUEL P JR | Director | 15 | 2006–2026 | ||
| FREER RICHARD J | Director,Officer; Director,Officer,TenPercentOwner | Chairman and COO; Chairman & Chief Operating Off; Chairman & COO; Chief Executive Officer; Chief Operating Officer; COO; COO and Chairman | 10 | 2006–2013 | |
| BRENNAN JAMES H | Director,Officer; Officer | Controller; VP Financial Operations | 2 | 2006–2009 | |
| HARRIS ROBERT B | Director,Officer; Officer | President; President and CEO; President & CEO | 6 | 2006–2009 | |
| REYNOLDS THOMAS R | Director,Officer; Officer | Executive VP; Secretary; Senior Vice President; Senior VP/Secretary; Vice President | 6 | 2006–2009 | |
| Krueger Gerald P | Director | 2 | 2006 | ||
| D'Sylva Paul | Director; Director,Officer | CEO | 5 | 2007–2010 | |
| Ede Nick | OfficerOther | Chief Scientific Officer | 1 | 2007 | |
| Hagan Nick | Officer | CEO of subsidiary | 1 | 2007 | |
| Hayden Daniel O | Director | 1 | 2007 | person page Fuzzy | |
| CAUSEY JAMES D | Director | 1 | 2008 | ||
| MCAFEE DONALD A | Director | 1 | 2008 | ||
| PharmAust Chemistry Ltd. | TenPercentOwner | 2 | 2008 | ||
| GUO WILLIAM X | Director,Officer | Chairman | 1 | 2008 | |
| HedgePath, LLC | Director; TenPercentOwner | 6 | 2013–2017 | ||
| ODONNELL FRANCIS E JR | Director,Officer; Director,Officer,TenPercentOwner | Chief Executive Officer; Executive Chairman; See Remarks | 9 | 2013–2026 | person page Fuzzy |
| Hasara Garrison J. | Officer | CEO, Secretary & Treasurer; CFO and Treasurer | 8 | 2013–2020 | |
| VIRCA NICHOLAS J | Director,Officer; Officer | President and CEO | 6 | 2013–2020 | |
| Cross Stefan | Director | 5 | 2014–2018 | ||
| Mayne Pharma Group Ltd | TenPercentOwner | 12 | 2014–2021 | ||
| Mayne Pharma International Pty Ltd | TenPercentOwner | 12 | 2014–2021 | ||
| Mayne Pharma Ventures Pty Ltd | Director; Director,TenPercentOwner; TenPercentOwner | 13 | 2014–2021 | ||
| Ono Richard Dana | Director | 9 | 2014–2020 | ||
| Watson W. Mark | Director | 12 | 2014–2020 | person page Fuzzy | |
| MAGRAB E. BRENDAN | Director; Director,Officer | Chairman of the Board | 5 | 2016–2019 | |
| Martin Robert Daniel | Director | 7 | 2016–2020 | ||
| Peattie Debra | Director | 4 | 2019–2020 | ||
| MCNULTY JAMES A | Officer; Officer,TenPercentOwner; TenPercentOwner | Chief Financial Officer; CHIEF FINANCIAL OFFICER; See Remarks | 6 | 2022–2026 | |
| Vasisht Niraj | Director | 3 | 2022–2026 | ||
| Yanez Michelle | Director | 6 | 2022–2026 | ||
| Black Robe Capital LLC | TenPercentOwner | 2 | 2023–2026 | ||
| Donovan James Joseph III | TenPercentOwner | 1 | 2023 | ||
| TPB 2012 LLC | TenPercentOwner | 1 | 2023 | ||
| OSMAN RONALD E | Director,TenPercentOwner | 5 | 2023–2026 | ||
| Ronald E Osman Irrevocable Trust III | TenPercentOwner | 5 | 2023–2026 | ||
| Jerman Michael Allen | Director | 3 | 2024–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2016-04-22 | HedgePath Pharmaceuticals, Inc. | Pharmaceuticals | $5,500,000 | $600,000 | 3 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | INHIBITOR THERAPEUTICS, INC. | FL | State business registries | name and state |
| Plan sponsor | COMMONWEALTH BIOTECHNOLOGIES, INC. | VA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | HedgePath Pharmaceuticals, Inc. | FL | Form D private offerings | CIK (EXACT) |
| SEC filer | Inhibitor Therapeutics, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | INHIBITOR Therapeutics, Inc. | FL | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | COMMONWEALTH BIOTECHNOLOGIES, INC. | EIN (EXACT) | ||
| Person page | Daniel O Hayden | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Francis E O'Donnell Jr | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer,TenPercentOwner) | |
| Person page | W Mark Watson | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, FL first:
- SANO CORP FL
- CTT PHARMACEUTICAL HOLDINGS, INC. FL
- GENEREX BIOTECHNOLOGY CORP FL
- BIOMOLECULAR LIFE HOLDINGS, INC. FL
- Alaunos Therapeutics, Inc. FL
- ORAGENICS INC FL
- Polomar Health Services, Inc. FL
- ACCENTIA BIOPHARMACEUTICALS INC FL
- NOMAD POWER SOLUTIONS, INC. FL
- CATALYST PHARMACEUTICALS, INC. FL
In other datasets, the same topic (Health) in FL:
- Nonprofit: 414 WELLWOMEN INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health